Shiri holds a PhD in cell, molecular and developmental biology from Tufts University, USA. She has been a medical writer since 2009. Shiri worked as a medical writer and medical writing team leader at Teva until 2014. Currently, Shiri is the head of the medical writing department at Bioforum. Shiri is experienced in managing medical writing projects of early and late phase product development. Her expertise encompasses study-specific documents such as protocols and clinical study reports, as well as development-program documents such as investigator’s brochures and summaries of efficacy and safety. Shiri is experienced in close collaboration with multi-disciplinary clinical development teams, specifically safety, biostatistics and data management aimed at producing the highest-quality, most regulation-compliant, clear and informative documents while adhering to timelines. In addition to regulatory documents, Shiri is an expert in writing scientific journal articles. She writes and edits manuscripts, and teaches workshops to medical doctors and scientists on this subject. Shiri is a lecturer at Tel Aviv University School of Medicine leading a course on medical writing to graduate students of regulatory science.

Lisa is a Senior Partner of Trilogy Writing & Consulting. Aside from management activities, she leads client projects, with extensive experience in a variety of documents. Lisa has a special interest in writing for the public, pharmacovigilance, and in patient information. Following a PhD and post doc. in Pathology at Cambridge, Lisa began her medical writing career in 2000. Since then, she has been involved in the European Medical Writers Association (EMWA) as a member of the Educational Committee, mentor, leader, and assessor of workshops, and is a member of the American Medical Writers Association (AMWA)’s Executive Forum, and teaches and reviews workshops for AMWA. Lisa holds an EMWA professional development certificate, is a visiting lecturer for King’s College London, a member of TOPRA, DIA, and PIPA, initiated and chaired the EMWA PV and Communicating with the Public Special Interest Groups, is chair of the Geoff Hall Scholarship Committee, section editor of the ‘Medical Communications and Writing for the Public’ section of Medical Writing, serves on the advisory board for the Pharmaceutical Business Conference Group, and is a Fellow of the Royal Society of Medicine.

Sarah is Founder and Director of Azur Health Science, a regulatory writing consultancy based in France. Having been medical writing since 2006 in a variety of companies, she believes that everyone has their own unique contribution to give to our industry, which now necessitates understanding how we can adapt to and embrace current trends and challenges. Sarah has been involved in mentoring new medical writers since an early stage of her career, she provides training to new writers as well as regular workshops at EMWA conferences. She holds a first degree in Biology, a Postgraduate Certificate in International Health Technology Assessment, Pricing and Reimbursement and an executive MBA with a focus in Healthcare Management. She is the current EMWA president.